Drug-induced hyperamylasemia
Alerts and Notices
Important News & Links
Synopsis
Hyperamylasemia is an abnormally high level of the enzyme amylase in the blood. Amylase is a crucial enzyme in the metabolism of starches. It is physiologically most abundant in the pancreas and salivary glands, but many other organs produce some quantity of the enzyme. Injury to these organs may lead to hyperamylasemia. Pancreatitis, diabetic ketoacidosis, and malignancy are among the common causes of hyperamylasemia. Drugs, however, may induce injury to amylase-containing tissue or change serum binding of amylase, resulting in hyperamylasemia. Drugs reported to have caused hyperamylasemia include opiates, acetaminophen, lamivudine, and valproic acid.
Codes
ICD10CM:
R74.8 – Abnormal levels of other serum enzymes
T50.995A – Adverse effect of other drugs, medicaments and biological substances, initial encounter
SNOMEDCT:
275739007 – Serum amylase raised
278993004 – Drug-induced
R74.8 – Abnormal levels of other serum enzymes
T50.995A – Adverse effect of other drugs, medicaments and biological substances, initial encounter
SNOMEDCT:
275739007 – Serum amylase raised
278993004 – Drug-induced
Differential Diagnosis & Pitfalls
To perform a comparison, select diagnoses from the classic differential
Subscription Required
Best Tests
Subscription Required
Drug Reaction Data
Subscription Required
References
Subscription Required
Last Updated:12/22/2015
Drug-induced hyperamylasemia